Amarin Corp Plc (AMRN)

[Biobillionair]

Alm- Amarin has been on the wrong strategic path for years, this must change. An injunction is best for patients and shareholders. After an injunction is issued, Amarin can focus on DTC advertising and massive script growth. Without an injunction I doubt Amarin engages in a marketing strategy and script growth stagnates, this is the wrong pathway for patients and shareholders. If the courts refuse to grant an injunction Amarin should put all resources into growing a European pharma and launch its own generic in US.

Doing nothing IMO is the wrong move.

BB

Stagnation of scripts:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155915977